| 12802 | A | 203720 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | FRESENIUS KABI | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | AP | ["AP"] | 2018-05-11 | May 11, 2018 | No | No | No | RX | FRESENIUS KABI ANTI INFECTIVES SRL | f1cf82dc286f295fbaa9fa8713d36c151ddd6414660a412fb45600c0ec5e9a6e |
| 12803 | A | 206204 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | FRESENIUS KABI USA | EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL | AP | ["AP"] | 2018-05-11 | May 11, 2018 | No | No | No | RX | FRESENIUS KABI USA LLC | e684bd60c7c79d86defba30d362277c9679deff1cdb9c942d529e70e6906d21a |
| 12804 | A | 065386 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | HOSPIRA INC | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | | [] | 2009-09-15 | Sep 15, 2009 | No | No | No | DISCN | HOSPIRA INC | c434cf55cafb9122e054b93affff83884f25a54b2d111062efcac0c05321e811 |
| 12805 | A | 065386 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | HOSPIRA INC | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | | [] | 2009-09-15 | Sep 15, 2009 | No | No | No | DISCN | HOSPIRA INC | d84204db0e3acd914e3af98734964797a58c75c81b1554bae6b492c09a16f5e5 |
| 12806 | A | 065386 | 003 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | HOSPIRA INC | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | | [] | 2009-09-15 | Sep 15, 2009 | No | No | No | DISCN | HOSPIRA INC | c550258d06a03a724f2ce33491f501f4c0819ccb44f094159dff2d43c5a5f63b |
| 12807 | A | 065446 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | HOSPIRA INC | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | | [] | 2009-09-15 | Sep 15, 2009 | No | No | No | DISCN | HOSPIRA INC | 3d0864eaf884d8e76a8a1af873be428d4ca4ed619b4f470180daf8b08d93b1a9 |
| 12808 | A | 065523 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | ISTITUTO BIO ITA SPA | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | AP | ["AP"] | 2011-05-31 | May 31, 2011 | No | No | No | RX | ISTITUTO BIOCHIMICO ITALIANO SPA | 506632816ec7f2e9752a1e56bcac02aeea0acf9b6ec323be83da237efd53b58e |
| 12809 | A | 065523 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | ISTITUTO BIO ITA SPA | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | AP | ["AP"] | 2011-05-31 | May 31, 2011 | No | No | No | RX | ISTITUTO BIOCHIMICO ITALIANO SPA | 75d8f39f96acd1141bac91613e7de4384dce0ce456094e867e30eea178fd0346 |
| 12810 | A | 065523 | 003 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | ISTITUTO BIO ITA SPA | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | AP | ["AP"] | 2011-05-31 | May 31, 2011 | No | No | No | RX | ISTITUTO BIOCHIMICO ITALIANO SPA | a4efb17ac34d32bd354121f835d946404787a6a45bda5bba5af82cc7d10691d1 |
| 12811 | A | 090498 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | ISTITUTO BIO ITA SPA | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | AP | ["AP"] | 2011-05-31 | May 31, 2011 | No | No | No | RX | ISTITUTO BIOCHIMICO ITALIANO SPA | 3fe66fb2fb0513f453b5aab0df171ab444519001815a7d3191a0b227d51c0193 |
| 12812 | A | 065458 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | MYLAN LABS LTD | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | AP | ["AP"] | 2014-08-15 | Aug 15, 2014 | No | No | No | RX | MYLAN LABORATORIES LTD | 0ca11740d4faaf0ea92266408b9bc9acf180cf1392369bad8bd9d3ff9377d1f9 |
| 12813 | A | 065458 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | MYLAN LABS LTD | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | | [] | 2014-08-15 | Aug 15, 2014 | No | No | No | DISCN | MYLAN LABORATORIES LTD | 1461dab045e61ef5c04f22938f8a54f564a1f7d0540e5bf2c2237f53ed192d3e |
| 12814 | A | 065458 | 003 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | MYLAN LABS LTD | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | AP | ["AP"] | 2014-08-15 | Aug 15, 2014 | No | No | No | RX | MYLAN LABORATORIES LTD | 6e707a3409cd3e5d11f2335371257ad3087f1dbaefc3fbe4b382091460a6e634 |
| 12815 | A | 207847 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | PROVEPHARM SAS | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | AP | ["AP"] | 2017-01-13 | Jan 13, 2017 | No | No | No | RX | PROVEPHARM SAS | 9e5c0f3d83830ce582a529297e17121d1b2d87cea7b1c5dc3b029377fa275816 |
| 12816 | A | 207848 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | PROVEPHARM SAS | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | AP | ["AP"] | 2017-01-13 | Jan 13, 2017 | No | No | No | RX | PROVEPHARM SAS | 78797c69f6a2037f0c70dd30a288ac9676ef176aed88328c310b9c2dfc502105 |
| 12817 | A | 207847 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | PROVEPHARM SAS | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | AP | ["AP"] | 2017-01-13 | Jan 13, 2017 | No | No | No | RX | PROVEPHARM SAS | cbe54a85c42344c6d08e71ecfdd976a63da22b554b88f5951e16cf5d7a84e990 |
| 12818 | A | 207847 | 003 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | PROVEPHARM SAS | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | AP | ["AP"] | 2017-01-13 | Jan 13, 2017 | No | No | No | RX | PROVEPHARM SAS | 4608827822bf1d5722824c50793077db731a7191b0284afc33caa5168823b7f9 |
| 12819 | A | 207848 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | PROVEPHARM SAS | EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL | AP | ["AP"] | 2018-05-11 | May 11, 2018 | No | No | No | RX | PROVEPHARM SAS | c83459f14ebe576ea51700b7cd75e409299d00a92fcdaf00cc34e9d25749ae2f |
| 12820 | A | 204959 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | QILU | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | AP | ["AP"] | 2018-08-10 | Aug 10, 2018 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | a2a013b75f9e34d55ae4cd6a6bda6debd0e4f208c14a7dbb19746f4f46993026 |
| 12821 | A | 204959 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | QILU | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | AP | ["AP"] | 2018-08-10 | Aug 10, 2018 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | 5f9de23ef66ef9ff99b721af988cdf14d0b8c781ce0d41d3e406e88fc3c048ad |
| 12822 | A | 204959 | 003 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | QILU | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | AP | ["AP"] | 2018-08-10 | Aug 10, 2018 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | 85def98c23d63969faa8630500cc6ce1b3d1a22b4fbd86791c6b40f5ec383db9 |
| 12823 | A | 208674 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SAGENT PHARMS INC | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | AP | ["AP"] | 2021-02-16 | Feb 16, 2021 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | 53bcde540d165daef4baa6a46bc136d785eca141406c59e1a1c22624d521b6cd |
| 12824 | A | 208674 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SAGENT PHARMS INC | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | AP | ["AP"] | 2021-02-16 | Feb 16, 2021 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | f8bd2108d92023bfe265ad549e70c58f9e6e96f22ea05252b98224c49d52dc5e |
| 12825 | A | 208674 | 003 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SAGENT PHARMS INC | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | AP | ["AP"] | 2021-02-16 | Feb 16, 2021 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | a2e6c41e06897151679a025a6064dbbd13cb4b946f1e7da40bfd9886163c3291 |
| 12826 | A | 208675 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SAGENT PHARMS INC | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | AP | ["AP"] | 2021-02-16 | Feb 16, 2021 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | d3aeb43f1b92fac5f5141d97faa405fbeb2d90b182e25599dbe7d72a38ad6d72 |
| 12827 | A | 065362 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SANDOZ | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | AP | ["AP"] | 2010-10-21 | Oct 21, 2010 | No | No | No | RX | SANDOZ INC | 2ae1fd3058cacf25cb96e2d4af0bacba3a3034da9762cb88b40278f201ccfdf0 |
| 12828 | A | 065363 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SANDOZ | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | AP | ["AP"] | 2010-10-21 | Oct 21, 2010 | No | No | No | RX | SANDOZ INC | 9e16cc64ec91649e4de0ed824bca19ce1a9383bb6df44edeaee01add50fb3da4 |
| 12829 | A | 065362 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SANDOZ | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | AP | ["AP"] | 2010-10-21 | Oct 21, 2010 | No | No | No | RX | SANDOZ INC | fe3d2f4a50ee1c75c94f69d45776214c3a3b4e381f533b26d59c13fa1ef78ac3 |
| 12830 | A | 065363 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SANDOZ | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | AP | ["AP"] | 2010-10-21 | Oct 21, 2010 | No | No | No | RX | SANDOZ INC | 77ba083060515c78dbfe72ad1dcd5c09699349061ced3cbe17e28e6ea9544f4c |
| 12831 | A | 065362 | 003 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SANDOZ | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | AP | ["AP"] | 2010-10-21 | Oct 21, 2010 | No | No | No | RX | SANDOZ INC | 8664d2141f4a3918c1623414bb66850337269ea038396f68305b7579164a3a60 |
| 12832 | A | 065363 | 003 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SANDOZ | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | AP | ["AP"] | 2010-10-21 | Oct 21, 2010 | No | No | No | RX | SANDOZ INC | e096ec01d74d6fe4c44284e192ac3379ce97f99cab6b448a68661b29411ca8a9 |
| 12833 | A | 203557 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | SANDOZ INC | EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL | AP | ["AP"] | 2014-10-29 | Oct 29, 2014 | No | No | No | RX | SANDOZ INC | e478c5ec46ef855af3a126b97944177e33c6bad2e46aee4d35c1ce000be85c73 |
| 12834 | A | 206996 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | WOCKHARDT BIO AG | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | AP | ["AP"] | 2017-03-22 | Mar 22, 2017 | No | No | Yes | RX | WOCKHARDT BIO AG | 9f8a04cc2bddcf145a234334818dca95986fddc52f506a7f8ce584b5ac47e0f9 |
| 12835 | A | 206996 | 002 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | WOCKHARDT BIO AG | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | AP | ["AP"] | 2017-03-22 | Mar 22, 2017 | No | No | Yes | RX | WOCKHARDT BIO AG | 72971c787d4f2084fe6e6b759d783477ab3f69607da4e28ff455fb833e760feb |
| 12836 | A | 206996 | 003 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | WOCKHARDT BIO AG | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | AP | ["AP"] | 2017-03-22 | Mar 22, 2017 | No | No | Yes | RX | WOCKHARDT BIO AG | d846994d053581dc0fffe7053d9947984d7b5ac5fdab0da5b925e22bdf420535 |
| 12837 | A | 207146 | 001 | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPERACILLIN AND TAZOBACTAM | WOCKHARDT BIO AG | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | AP | ["AP"] | 2017-03-17 | Mar 17, 2017 | No | No | Yes | RX | WOCKHARDT BIO AG | 3fa5aee44a7155751fbca5b66a3696a24fa85d8522056d0313a2550969a49941 |
| 12838 | A | 062750 | 001 | PIPERACILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPRACIL | WYETH PHARMS INC | EQ 2GM BASE/VIAL | | [] | 1987-10-13 | Oct 13, 1987 | No | No | No | DISCN | WYETH PHARMACEUTICALS INC | e2b41396e11c233965051a46a24ff407c1e92b7848a33c9cd26626add87cec16 |
| 12839 | N | 050545 | 002 | PIPERACILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPRACIL | WYETH PHARMS INC | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | WYETH PHARMACEUTICALS INC | f1e8e54e9a181d049de79f96a245908f591d926dbd2d5c23f7910903785050ed |
| 12840 | A | 062750 | 002 | PIPERACILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPRACIL | WYETH PHARMS INC | EQ 3GM BASE/VIAL | | [] | 1987-10-13 | Oct 13, 1987 | No | No | No | DISCN | WYETH PHARMACEUTICALS INC | c3533b1e49c92be714eb5844aabb8e5ba19d835f8a8e941bd80c74d6fe8b0aca |
| 12841 | N | 050545 | 003 | PIPERACILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPRACIL | WYETH PHARMS INC | EQ 3GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | WYETH PHARMACEUTICALS INC | 8c00e670638669329e8034b03ee919ed5359d09da98bd05d87c87a05d0237632 |
| 12842 | A | 062750 | 003 | PIPERACILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPRACIL | WYETH PHARMS INC | EQ 4GM BASE/VIAL | | [] | 1987-10-13 | Oct 13, 1987 | No | No | No | DISCN | WYETH PHARMACEUTICALS INC | 84e40e47f9f250f79b67555a31e8ce51691163f9a969f082ad3844141fa117f5 |
| 12843 | N | 050545 | 004 | PIPERACILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPRACIL | WYETH PHARMS INC | EQ 4GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | WYETH PHARMACEUTICALS INC | 3d865f489d5f7a879be669a018c2161e1255332cd8d24366559b3d5228048ca6 |
| 12844 | N | 050545 | 006 | PIPERACILLIN SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PIPRACIL | WYETH PHARMS INC | EQ 40GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1985-09-30 | Sep 30, 1985 | No | Yes | No | DISCN | WYETH PHARMACEUTICALS INC | 1174626e3e93d1215a369f24822fc15004c22eb7a4fdfb4528eea0b203ffaf22 |
| 12845 | N | 018261 | 001 | OXYTOCIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PITOCIN | PAR STERILE PRODUCTS | 10USP UNITS/ML (10USP UNITS/ML) | AP | ["AP"] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | PAR STERILE PRODUCTS LLC | 1cf4257d62797b5197c12552e55fb103ddef25d9d385dac30f5f11a50a65d73c |
| 12846 | N | 018261 | 002 | OXYTOCIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PITOCIN | PAR STERILE PRODUCTS | 100USP UNITS/10ML (10USP UNITS/ML) | AP | ["AP"] | 2007-07-27 | Jul 27, 2007 | No | Yes | No | RX | PAR STERILE PRODUCTS LLC | 9f4d977bc5564732c795dccc853e9e5fc15981785197a3de5163b8bee086ce7a |
| 12847 | N | 018261 | 003 | OXYTOCIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PITOCIN | PAR STERILE PRODUCTS | 500USP UNITS/50ML (10USP UNITS/ML) | | [] | 2012-09-05 | Sep 5, 2012 | No | Yes | No | RX | PAR STERILE PRODUCTS LLC | 61be2ef790a7a250773f8c88afb61ccdfff4b0b9920d9cf3d6a71ff714a6f5db |
| 12848 | N | 003402 | 001 | VASOPRESSIN TANNATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PITRESSIN TANNATE | PARKE DAVIS | 5PRESSOR UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | PARKE DAVIS DIV WARNER LAMBERT CO | b153995bc5524c45e5474155e8d7d29903b83935fd7050b062764944c82023df |
| 12849 | N | 017451 | 001 | DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER | BAXTER HLTHCARE | 5GM/100ML;30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | BAXTER HEALTHCARE CORP | 83e3285a5a1897e6d82f8d7d943338544da5d178528e6c19f4e0f73aef80b014 |
| 12850 | N | 017378 | 001 | MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER | BAXTER HLTHCARE | 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | BAXTER HEALTHCARE CORP | 1d7938a4c46ee049f2afb90d6bbbff5666ee0e337a2d994dd9415a350100b21f |
| 12851 | N | 017385 | 001 | DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER | BAXTER HLTHCARE | 5GM/100ML;32MG/100ML;128MG/100ML;234MG/100ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BAXTER HEALTHCARE CORP | 73e88f222f2b90b9d458ba51db9863d919183ab7bddac80815a93c464b29899d |